Which clinical presentation is most indicative of a patient with mild persistent asthma?

Asthma classification is based on the frequency of daytime symptoms and nocturnal awakenings. Knowledge of the National Asthma Education and Prevention Program guidelines is required to correctly categorize severity, which dictates the pharmacological "step" therapy for pediatric patients. Choice A rationale Daily symptoms with nighttime episodes occurring more than once a week characterize moderate persistent asthma. This level of severity requires a higher dose of inhaled corticosteroids and potentially long-acting beta-agonists to maintain adequate pulmonary function. Choice B rationale Mild persistent asthma is defined by symptoms occurring more than twice weekly but less than daily. Nighttime awakenings happen three to four times per month. This classification necessitates the daily use of a low-dose anti-inflammatory controller. Choice C rationale Symptoms less than twice a week and nighttime episodes less than twice a month define intermittent asthma. This category typically only requires a rescue inhaler, such as albuterol, for as-needed use during acute bronchospasm episodes. Choice D rationale Continual symptoms throughout the day and frequent nighttime awakenings are indicative of severe persistent asthma. This reflects significantly limited physical activity and requires high-intensity therapy to prevent life-threatening exacerbations and maintain airway patency.